Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Publication year range
1.
Benef Microbes ; 15(4): 417-429, 2024 May 30.
Article in English | MEDLINE | ID: mdl-38821493

ABSTRACT

Recent metanalysis reported that certain probiotic strains, such as Limosilactobacillus reuteri and Lacticaseibacillus rhamnosus (LGG), seem effective for treatment of infantile colic of exclusively breastfed infants; some reports have also linked probiotics to have an immunological effect, however further investigation are needed to fully understand the exact mechanism. The objective of this study was to assay white blood cells, tumour necrosis factor (TNF)-α and interleukin (IL)-6 values in peripheral blood in subjects treated in a randomised, double-blind, placebo-controlled trial for infantile colic with LGG. Fifty-eight infants were enrolled and followed for a study period of 28 days. Parent were asked to record daily crying time using a structured cry diary. Peripheral white blood cells was assessed and RNA (mRNA) expression of TNF-α and IL-6 was measured using TaqMan real-time PCR-maternal amplification. Infants with colic treated with LGG showed a reduction in daily crying duration after 28 days of treatment and a reduction in values of IL-6 ( P < 0.005) and TNF-α ( P < 0.05); we observe also a significantly decreasing of IL-6 in the placebo group while decrease of TNF-α was not significant in this group. A significant decreased values of monocytes ( P < 0.05) was observed in infants treated with LGG. Our data therefore showed, in addition to crying time reduction, a significant decrease of TNF-α and a significant reduction of monocytes cells in colicky infants treated with LGG, compared to placebo group. This observation supports the hypothesis that probiotics may have anti-inflammatory properties. Further studies are needed to better understand the influence of probiotic on immunity cells.


Subject(s)
Colic , Interleukin-6 , Lacticaseibacillus rhamnosus , Leukocytes , Probiotics , Tumor Necrosis Factor-alpha , Humans , Colic/therapy , Probiotics/administration & dosage , Probiotics/therapeutic use , Interleukin-6/blood , Interleukin-6/genetics , Tumor Necrosis Factor-alpha/blood , Female , Double-Blind Method , Infant , Male , Prospective Studies , Leukocytes/immunology , Crying , Treatment Outcome
2.
Transplant Proc ; 43(4): 1052-4, 2011 May.
Article in English | MEDLINE | ID: mdl-21620051

ABSTRACT

Evaluation of BK virus replication is a fundamental tool in the monitoring of renal transplant recipients. Herein, we investigated the role of urine VP1 messenger RNA (mRNA) quantification and combined measurement of serum DNA and urine VP1 mRNA in 428 kidney allograft recipients. BK viremia and viruria were detected in 24 (5.6%) and 54 (12.6%) patients, respectively. A diagnosis of BKV-associated nephropathy (BKVAN) was established in 2 patients, both within the first year posttransplantation. Based on urine VP1 mRNA measurement, BKV replication was observed in 10 (2.1%) patients, 2 of whom displayed BKVAN. Urine VP1 mRNA was detected in all cases in association with viremia except 5 and in all cases with viruria. No difference among VP1 mRNA levels was noted between the 2 BKVAN patients and the highest values in patients without BKVAN. The urine VP1 mRNA result by analysis using the operating characteristics was not superior to viremia, despite the improvement obtained with the combined measurement of viremia (cut-off, 16,000 copies/mL) and urine VP1 mRNA (>10,000 copies/10(3) cells). In conclusion, VP1 mRNA measurements may complement viremia and viruria to monitor BKV replication, although its use is limited by its technical complexity in comparison with DNA detection.


Subject(s)
BK Virus/genetics , Capsid Proteins/genetics , DNA, Viral/blood , Kidney Transplantation/adverse effects , Polyomavirus Infections/diagnosis , RNA, Messenger/urine , Virus Replication , Aged , BK Virus/pathogenicity , Biomarkers/blood , Biomarkers/urine , Female , Humans , Italy , Male , Middle Aged , Polyomavirus Infections/virology , Predictive Value of Tests , Prospective Studies , ROC Curve , Time Factors , Treatment Outcome , Viral Load
3.
Minerva Med ; 102(2): 103-8, 2011 Apr.
Article in English, Italian | MEDLINE | ID: mdl-21483396

ABSTRACT

AIM: The aim of this study was to report most recent data regarding the occurrence of influenza A virus H1N1v in the lower respiratory tract from a cohort of hospitalized adult patients during the winter season 2009/2010 and investigated the main clinical features and outcomes. METHODS: A total of 130 consecutive BAL specimens (collected from October 2009-March 2010) of 101 patients were retrospectively analyzed for influenza A virus H1N1v positivity using a commercial kit. RESULTS: Overall, 19/130 (14.6%) BAL specimens from 17/101 (16.8%) patients were positive for the novel influenza A H1N1v virus. H1N1v resulted significantly more prevalent in immunocompetent subjects. As regards clinical features, H1N1v resulted more prevalent in respiratory insufficiency or acute respiratory illness. Thirteen patients died during the analytic period; three of them (23.1%) resulted positive to H1N1v but no direct association has been made. CONCLUSION: Our cohort study of influenza A H1N1v detection in BAL from hospitalized adult patients confirms the overall moderate clinical impact of this virus, as reported in most reports worldwide. It remains to be evaluated the role of reassortment with influenza virus strains circulating in the winter season 2010/2011 and its potential pathogenicity.


Subject(s)
Bronchoalveolar Lavage , Influenza A Virus, H1N1 Subtype/isolation & purification , Influenza, Human/virology , Seasons , Adult , Aged , Aged, 80 and over , Female , Hospitalization , Humans , Influenza A Virus, H1N1 Subtype/classification , Influenza, Human/epidemiology , Italy/epidemiology , Lung Transplantation/statistics & numerical data , Male , Middle Aged , Pneumonia, Viral/epidemiology , Pneumonia, Viral/virology , Respiratory Insufficiency/epidemiology , Respiratory Insufficiency/virology , Retrospective Studies , Young Adult
4.
Minerva Med ; 100(5): 349-55, 2009 Oct.
Article in English | MEDLINE | ID: mdl-19910888

ABSTRACT

AIM: The epidemiology of lower respiratory tract (LRT) viral infections in adults is probably underestimated and the high frequency of multiple viral infections complicates the evaluation of the possible role of the single viruses. The aim of this study was to investigate the clinical epidemiology and impact of respiratory viral pathogens, in particular of those singularly detected, in bronchoalveolar lavage (BAL) specimens from hospitalized adult patients. METHODS: A panel for the detection of 16 respiratory viruses was used to prospectively evaluate 324 consecutive specimens obtained from 219 patients over a full-year period. RESULTS: Two-hundred-twenty-one specimens (68.2%) were positive for at least one virus, 119/324 (36.7%) to a single viral agent. The most commonly detected viruses were herpesviruses HHV-7 (26.2%), human cytomegalo-virus (HCMV, 22.2%), HHV-6 (19.8%), EBV (12.7%), enteroviruses and rhinoviruses (both 11.7%), parainfluenza viruses (4.9 %), and metapneumovirus (4.0%). Human cytomegalo-virus was significantly more prevalent as single viral pathogen with a viral load >105 copies/ml associated to pneumonia in solid organ transplant recipients. Other viral pathogens might account for some cases of pneumonia or respiratory insufficiency, although multiple infections were common. CONCLUSIONS: The use of a comprehensive diagnostic panel for respiratory viral infections may be useful to clarify the epidemiology and clinical impact of viral pathogens in hospitalized adult patients. The occurrence of multiple infections is a common finding and results should be interpreted taking into account the clinical context as well as viral load and the biological characteristics of each virus.


Subject(s)
Bronchoalveolar Lavage Fluid/virology , Cross Infection/epidemiology , Cross Infection/virology , Inpatients/statistics & numerical data , Pneumonia, Viral/epidemiology , Virus Diseases/epidemiology , Viruses/isolation & purification , Adolescent , Adult , Aged , Aged, 80 and over , Cytomegalovirus/isolation & purification , Cytomegalovirus Infections/epidemiology , Epstein-Barr Virus Infections/epidemiology , Female , Herpesvirus 4, Human/isolation & purification , Hospitalization , Humans , Italy/epidemiology , Male , Metapneumovirus/isolation & purification , Middle Aged , Paramyxoviridae/isolation & purification , Paramyxoviridae Infections/epidemiology , Picornaviridae Infections/epidemiology , Pneumonia, Viral/virology , Prevalence , Prospective Studies , Rhinovirus/isolation & purification , Virus Diseases/virology
SELECTION OF CITATIONS
SEARCH DETAIL
...